Trends in hospital treatment of ventricular arrhythmias among Medicare beneficiaries, 1985 to 1995

American Heart Journal

Volumn 144, Issue 3, 2002, Pages 413-421

  McDonald, Kathryn M ^a   Hlatky, Mark A ^a   Saynina, Olga ^c   Geppert, Jeffrey ^c   Garber, Alan M ^a,b,c,d   McClellan, Mark B ^a,b,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; DEFIBRILLATION; FEMALE; HEALTH CARE COST; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE ARRHYTHMIA; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; SURVIVAL RATE; UNITED STATES;

EID: 0036733459     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjh.2002.125498     Document Type: Article

References (35)

1. Prediction of sudden death by electrophysiologic studies in high risk patients surviving acute myocardial infarction
2. Identifying patients at risk of sudden death after myocardial infarction: Value of the response to programmed stimulation, degree of ventricular ectopic activity and severity of left ventricular dysfunction
3. Prognostic significance of ventricular tachycardia and fibrillation induced at programmed stimulation and delayed potentials detected on the signal-averaged electrocardiograms of survivors of acute myocardial infarction
4. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings
5. Early experience with an implantable cardioverter
6. Acute myocardial infarction in the Medicare population: Process of care and clinical outcomes
7. Temporal changes in the care and outcomes of elderly patients with acute myocardial infarction, 1987 through 1990
8. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables
9. The influence of clinical risk factors on the use of angiography and revascularization after acute myocardial infarction
10. Use of direct angioplasty for treatment of patients with acute myocardial infarction in hospitals with and without on-site cardiac surgery
11. Hospital mortality in acute myocardial infarction in the era of reperfusion therapy (the Myocardial Infarction Triage and Intervention Project)
12. Use and accuracy of state death certificates for classification of sudden cardiac death in high-risk populations
13. Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias
14. Automatic implantable cardioverter defibrillator
15. Long-term outcome with the automatic cardioverter-defibrillator
16. Management of survivors of cardiac arrest: Is electrophysiologic testing obsolete in the era of implantable defibrillators?
17. Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease
18. Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest
19. Mortality benefits and the implantable cardioverter-defibrillator
20. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg)
21. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: An international multicenter study
22. Implantable cardioverter-defibrillators: Implications for the nonelectrophysiologist
23. Guidelines for clinical intracardiac electrophysiologic studies: A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Assess Clinical Intracardiac Electrophysiologic Studies)
24. Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Pacemaker Implantation)
25. Implantable cardioverter defibrillators in cardiovascular practice: Report of the Policy Conference of the North American Society of Pacing and Electrophysiology
26. Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures). Developed in collaboration with the North American Society of Pacing and Electrophysiology
27. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation)
28. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction
29. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia
30. Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone
31. A randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH)
32. Design and results of the antiarrhythmics vs. implantable defibrillators (AVID) registry
33. Cardiac arrest and resuscitation: A tale of 29 cities
34. Estimating effectiveness of cardiac arrest interventions: A logistic regression survival model